Trials / Conditions / Recurrent Skin Carcinoma
Recurrent Skin Carcinoma
5 registered clinical trials studyying Recurrent Skin Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer NCT02964559 | Emory University | Phase 2 |
| Active Not Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph NCT02465060 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, NCT02318771 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Can NCT01727076 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer NCT00954226 | M.D. Anderson Cancer Center | Phase 1 |